Back

Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes

28 August 2022 (09:30 - 09:40)
Organised by:
Congress Presentation Part of: Obesity and diabetes: key role for risk factor management Diabetes and the Heart ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Saaima Parveen

Herlev and Gentofte Hospital, Copenhagen (Denmark)

2 More presentations in this session

Presentation thumbnail
Effects of dapagliflozin on cardiovascular and kidney events by baseline eGFR and UACR in patients with type 2 diabetes mellitus: A patient-level pooled analysis of DECLARE-TIMI 58 and DAPA-CKD trials
Doctor F. Moura (Boston, US)
Abstract Slides Video
Presentation thumbnail
Relationship of obesity to mortality in 47 399 patients from nationwide LIPIDOGRAM 2004-2015 cohort studies.
Doctor T. Osadnik (Zabrze, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Obesity and diabetes: key role for risk factor management

The Event

Event poster

ESC Congress 2022

28 August 2022 09:30 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on caring for kidney disease patients in a cardiology setting: what is important?
thumbnail
Congress Session
A new era in the management of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and cardiovascular complications
thumbnail
Congress Session
Clash of the titans: when cardiovascular and kidney diseases overlap

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources